Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma.
Shinriki S, Ueda M, Ota K, Nakamura M, Kudo M, Ibusuki M, Kim J, Yoshitake Y, Fukuma D, Jono H, Kuratsu J, Shinohara M, Ando Y. Shinriki S, et al. Among authors: yoshitake y. J Oral Pathol Med. 2010 Jan;39(1):41-7. doi: 10.1111/j.1600-0714.2009.00777.x. Epub 2009 Apr 21. J Oral Pathol Med. 2010. PMID: 19453393
Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Nomura T, Murakami R, Toya R, Teshima K, Nakahara A, Hirai T, Hiraki A, Nakayama H, Yoshitake Y, Ota K, Obayashi T, Yamashita Y, Oya N, Shinohara M. Nomura T, et al. Among authors: yoshitake y. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1347-52. doi: 10.1016/j.ijrobp.2009.03.055. Epub 2009 Jul 21. Int J Radiat Oncol Biol Phys. 2010. PMID: 19628343 Clinical Trial.
A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma.
Kawahara K, Nakayama H, Nagata M, Yoshida R, Hirosue A, Tanaka T, Nakagawa Y, Matsuoka Y, Kojima T, Takamune Y, Yoshitake Y, Hiraki A, Shinohara M. Kawahara K, et al. Among authors: yoshitake y. J Oral Pathol Med. 2014 May;43(5):350-6. doi: 10.1111/jop.12140. Epub 2013 Dec 10. J Oral Pathol Med. 2014. PMID: 24325353
Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
Yoshitake Y, Nakatsura T, Monji M, Senju S, Matsuyoshi H, Tsukamoto H, Hosaka S, Komori H, Fukuma D, Ikuta Y, Katagiri T, Furukawa Y, Ito H, Shinohara M, Nakamura Y, Nishimura Y. Yoshitake Y, et al. Clin Cancer Res. 2004 Oct 1;10(19):6437-48. doi: 10.1158/1078-0432.CCR-04-0841. Clin Cancer Res. 2004. PMID: 15475430
234 results